From: Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party
No-ATG
ATG
N = 144
N = 35
Relapse
77 (53.5%)
19 (54.3%)
GVHD
32 (22.2%)
6 (17.1%)
Infection
23 (16%)
5 (14.3%)
VOD
5 (3.5%)
3 (8.6%)
Idiopathic pneumonia
2 (1.4%)
0 (0%)
Hemorrhage
Other SCT-related
3 (2.1%)
2 (5.7%)